annual operating expenses:
$97.78M+$19.57M(+25.03%)Summary
- As of today (September 14, 2025), LGND annual total operating expenses is $97.78 million, with the most recent change of +$19.57 million (+25.03%) on December 31, 2024.
- During the last 3 years, LGND annual operating expenses has risen by +$18.76 million (+23.74%).
- LGND annual operating expenses is now -40.10% below its all-time high of $163.23 million, reached on December 31, 2005.
Performance
LGND Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$26.74M-$42.14M(-61.18%)Summary
- As of today (September 14, 2025), LGND quarterly total operating expenses is $26.74 million, with the most recent change of -$42.14 million (-61.18%) on June 30, 2025.
- Over the past year, LGND quarterly operating expenses has increased by +$3.77 million (+16.39%).
- LGND quarterly operating expenses is now -61.18% below its all-time high of $68.89 million, reached on March 31, 2025.
Performance
LGND quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
LGND Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.0% | +16.4% |
| 3 y3 years | +23.7% | +29.0% |
| 5 y5 years | +35.0% | +17.3% |
LGND Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.0% | +25.0% | -61.2% | +58.0% |
| 5 y | 5-year | -19.6% | +35.0% | -61.2% | +58.0% |
| alltime | all time | -40.1% | +1305.6% | -61.2% | +171.1% |
LGND Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $26.74M(-61.2%) |
| Mar 2025 | - | $68.89M(+129.4%) |
| Dec 2024 | $97.78M(+25.0%) | $30.03M(-0.4%) |
| Sep 2024 | - | $30.15M(+31.2%) |
| Jun 2024 | - | $22.98M(+35.8%) |
| Mar 2024 | - | $16.92M(-21.3%) |
| Dec 2023 | $78.20M(-26.4%) | $21.50M(+6.2%) |
| Sep 2023 | - | $20.26M(+9.0%) |
| Jun 2023 | - | $18.58M(+3.8%) |
| Mar 2023 | - | $17.90M(-55.7%) |
| Dec 2022 | $106.31M(+34.5%) | $40.36M(+67.2%) |
| Sep 2022 | - | $24.13M(+16.4%) |
| Jun 2022 | - | $20.73M(+16.3%) |
| Mar 2022 | - | $17.83M(-14.3%) |
| Dec 2021 | $79.02M(-35.0%) | $20.82M(-29.8%) |
| Sep 2021 | - | $29.66M(-4.3%) |
| Jun 2021 | - | $30.99M(+3.4%) |
| Mar 2021 | - | $29.97M(-42.2%) |
| Dec 2020 | $121.55M(+67.8%) | $51.85M(+86.0%) |
| Sep 2020 | - | $27.87M(+22.2%) |
| Jun 2020 | - | $22.80M(+25.3%) |
| Mar 2020 | - | $18.20M(+37.8%) |
| Dec 2019 | $72.42M(+10.4%) | $13.21M(-43.2%) |
| Sep 2019 | - | $23.27M(+0.3%) |
| Jun 2019 | - | $23.21M(+3.7%) |
| Mar 2019 | - | $22.38M(+11.9%) |
| Dec 2018 | $65.60M(+18.1%) | $20.00M(+32.3%) |
| Sep 2018 | - | $15.12M(-2.0%) |
| Jun 2018 | - | $15.43M(+2.5%) |
| Mar 2018 | - | $15.05M(-8.1%) |
| Dec 2017 | $55.54M(+16.1%) | $16.38M(+38.9%) |
| Sep 2017 | - | $11.79M(+3.7%) |
| Jun 2017 | - | $11.37M(-28.9%) |
| Mar 2017 | - | $15.99M(+22.7%) |
| Dec 2016 | $47.84M(+26.7%) | $13.03M(+6.8%) |
| Sep 2016 | - | $12.20M(+3.6%) |
| Jun 2016 | - | $11.78M(+8.8%) |
| Mar 2016 | - | $10.83M(+19.5%) |
| Dec 2015 | $37.76M(+8.8%) | $9.06M(+31.0%) |
| Sep 2015 | - | $6.92M(-38.4%) |
| Jun 2015 | - | $11.23M(+12.8%) |
| Mar 2015 | - | $9.96M(+13.2%) |
| Dec 2014 | $34.69M(+27.3%) | $8.80M(-9.9%) |
| Sep 2014 | - | $9.76M(+23.1%) |
| Jun 2014 | - | $7.93M(-3.4%) |
| Mar 2014 | - | $8.20M(+20.7%) |
| Dec 2013 | $27.26M(+1.3%) | $6.79M(-5.2%) |
| Sep 2013 | - | $7.17M(+13.3%) |
| Jun 2013 | - | $6.33M(+0.5%) |
| Mar 2013 | - | $6.30M(-6.8%) |
| Dec 2012 | $26.90M(+6.5%) | $6.76M(+5.8%) |
| Sep 2012 | - | $6.39M(+4.3%) |
| Jun 2012 | - | $6.13M(+74.9%) |
| Mar 2012 | - | $3.50M(-35.5%) |
| Dec 2011 | $25.27M(-22.7%) | $5.43M(-4.5%) |
| Sep 2011 | - | $5.68M(-19.9%) |
| Jun 2011 | - | $7.09M(+45.7%) |
| Mar 2011 | - | $4.87M(+81.5%) |
| Dec 2010 | $32.68M(+102.5%) | $2.68M(+1195.2%) |
| Sep 2010 | - | $207.00K(-94.9%) |
| Jun 2010 | - | $4.05M(+12.6%) |
| Mar 2010 | - | $3.60M(-387.8%) |
| Dec 2009 | $16.14M | -$1.25M(-128.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2009 | - | $4.43M(-5.8%) |
| Jun 2009 | - | $4.71M(-39.7%) |
| Mar 2009 | - | $7.81M(+315.4%) |
| Dec 2008 | $27.04M(-50.8%) | $1.88M(-72.5%) |
| Sep 2008 | - | $6.85M(+11.8%) |
| Jun 2008 | - | $6.12M(-47.6%) |
| Mar 2008 | - | $11.69M(+37.0%) |
| Dec 2007 | $54.94M(-60.6%) | $8.53M(+10.3%) |
| Sep 2007 | - | $7.73M(-48.0%) |
| Jun 2007 | - | $14.86M(-39.4%) |
| Mar 2007 | - | $24.53M(-23.7%) |
| Dec 2006 | $139.55M(-14.5%) | $32.15M(-24.1%) |
| Sep 2006 | - | $42.33M(-14.7%) |
| Jun 2006 | - | $49.60M(+9.3%) |
| Mar 2006 | - | $45.38M(+20.4%) |
| Dec 2005 | $163.23M(+1.3%) | $37.70M(-2.0%) |
| Sep 2005 | - | $38.46M(-7.6%) |
| Jun 2005 | - | $41.64M(-0.1%) |
| Mar 2005 | - | $41.69M(+10.0%) |
| Dec 2004 | $161.08M(+25.2%) | $37.88M(-11.0%) |
| Sep 2004 | - | $42.56M(+2.1%) |
| Jun 2004 | - | $41.68M(+7.0%) |
| Mar 2004 | - | $38.95M(+1.7%) |
| Dec 2003 | $128.70M(+28.1%) | $38.29M(+23.9%) |
| Sep 2003 | - | $30.91M(+1.6%) |
| Jun 2003 | - | $30.43M(+4.7%) |
| Mar 2003 | - | $29.07M(+6.3%) |
| Dec 2002 | $100.48M(+17.5%) | $27.34M(+3.6%) |
| Sep 2002 | - | $26.41M(+10.2%) |
| Jun 2002 | - | $23.96M(+5.2%) |
| Mar 2002 | - | $22.77M(+9.5%) |
| Dec 2001 | $85.53M(+23.6%) | $20.80M(+3.6%) |
| Sep 2001 | - | $20.09M(-9.0%) |
| Jun 2001 | - | $22.08M(-2.1%) |
| Mar 2001 | - | $22.56M(+15.1%) |
| Dec 2000 | $69.20M(+153.9%) | $19.60M(-10.1%) |
| Sep 2000 | - | $21.79M(-2.5%) |
| Jun 2000 | - | $22.34M(+10.1%) |
| Mar 2000 | - | $20.29M(-154.0%) |
| Dec 1999 | $27.26M(+64.5%) | -$37.60M(-273.0%) |
| Sep 1999 | - | $21.73M(-4.6%) |
| Jun 1999 | - | $22.78M(+12.0%) |
| Mar 1999 | - | $20.34M(-189.8%) |
| Dec 1998 | $16.57M(+63.9%) | -$22.66M(-167.0%) |
| Sep 1998 | - | $33.83M(+915.8%) |
| Jun 1998 | - | $3.33M(+20.3%) |
| Mar 1998 | - | $2.77M(-89.5%) |
| Dec 1997 | $10.11M(-1.0%) | $26.40M(+14.8%) |
| Sep 1997 | - | $23.00M(+6.5%) |
| Jun 1997 | - | $21.60M(+1.9%) |
| Mar 1997 | - | $21.20M(-6.6%) |
| Dec 1996 | $10.21M(+24.7%) | $22.70M(+4.6%) |
| Sep 1996 | - | $21.70M(+16.7%) |
| Jun 1996 | - | $18.60M(+16.3%) |
| Mar 1996 | - | $16.00M(-3.0%) |
| Dec 1995 | $8.18M(+17.6%) | $16.50M(+8.6%) |
| Sep 1995 | - | $15.20M(+61.7%) |
| Mar 1995 | - | $9.40M(+176.5%) |
| Dec 1994 | $6.96M(-51.1%) | $3.40M(+61.9%) |
| Sep 1994 | - | $2.10M(+5.0%) |
| Jun 1994 | - | $2.00M(0.0%) |
| Mar 1994 | - | $2.00M |
| Dec 1993 | $14.23M(+14.0%) | - |
| Dec 1992 | $12.48M | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual total operating expenses?
- What is the all time high annual operating expenses for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual operating expenses year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly operating expenses year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual total operating expenses?
The current annual operating expenses of LGND is $97.78M
What is the all time high annual operating expenses for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual total operating expenses is $163.23M
What is Ligand Pharmaceuticals Incorporated annual operating expenses year-on-year change?
Over the past year, LGND annual total operating expenses has changed by +$19.57M (+25.03%)
What is Ligand Pharmaceuticals Incorporated quarterly total operating expenses?
The current quarterly operating expenses of LGND is $26.74M
What is the all time high quarterly operating expenses for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly total operating expenses is $68.89M
What is Ligand Pharmaceuticals Incorporated quarterly operating expenses year-on-year change?
Over the past year, LGND quarterly total operating expenses has changed by +$3.77M (+16.39%)